322 - HPV Vaccination by Disability, Geography, and Sex in 2022

Abstract: HPV Vaccination by Disability, Geography, and Sex in 2022

Khadka S, Bienstock L, Akilesh S

NYU Langone Hospitals-Advance education in Pediatric Dentistry, Phoenix, AZ



Purpose: To evaluate the association between disability status and HPV vaccination among children ages 9–17 years, and to assess differences by geographic location and sex.

Methods: Cross-sectional analysis of the 2022 National Health Interview Survey Child Public Use File was conducted. The outcome was receipt of at least 1 HPV vaccine dose. Disability status, based on parent-reported functional limitations, was the primary exposure. Geographic location (metropolitan vs non-metropolitan) and sex were included as covariates. Vaccination coverage was estimated across groups, and prevalence ratios were calculated. Stratified analyses assessed variation by location and sex while accounting for complex survey design.

Results: Vaccination coverage was higher among children with disabilities compared to those without (44% vs 38%; prevalence ratio 1.17). Children in metropolitan areas had higher coverage than those in non-metropolitan areas (prevalence ratio 1.33). Female adolescents had slightly higher coverage than males (prevalence ratio 1.11). Stratified analyses showed consistent patterns without significant interaction effects.

Conclusions: HPV vaccination coverage varies by disability status, geographic location, and sex. Despite slightly higher uptake among children with disabilities, disparities persist, particularly in non-metropolitan areas. Targeted strategies addressing access and structural barriers are needed to improve equitable vaccine coverage.

Identify Supporting Agency and Grant Number: